Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction

2014645 citationsJournal Articlebronze Open Access

Authors

Gilles Montalescot · Inserm

Arnoud W.J. van ‘t Hof · Isala

Frédéric Lapostolle · Hôpital Avicenne

Johanne Silvain · Inserm

Jens Flensted Lassen · Aarhus University Hospital

Leonardo Bolognese · Azienda Usl 8 Arezzo

Warren J. Cantor ·

Abstract

Prehospital administration of ticagrelor in patients with acute STEMI appeared to be safe but did not improve pre-PCI coronary reperfusion. (Funded by AstraZeneca; ATLANTIC ClinicalTrials.gov number, NCT01347580.).

Topics & Keywords

Antiplatelet Therapy and Cardiovascular Diseases Acute Myocardial Infarction Research Venous Thromboembolism Diagnosis and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 371, Issue 11, pp. 1016-1027

DOI: 10.1056/nejmoa1407024

Field-Weighted Citation Impact: 51.91